Omega 3 supplements delay deterioration in mild Alzheimers

Omega-3 fatty acid crosses the blood-brain barrier and accumulates in the central nervous system tissues lowering disease markers in patients with mild Alzheimer’s disease a new study shows, giving hope that disease progression can be delayed if treated with the supplement early. The findings were from a sub-study of patients included in the larger double-blind, placebo-controlled OmegAD study, which also observed that in patients with mild Alzheimer’s disease (AD) and...